SCHEMBL23740355

SCHEMBL23740355

c1ccc(-c2ccc(-c3nc(-c4cccc5oc6ccc(-n7c8ccc(-c9ccccc9)cc8c8cc9ccccc9cc87)cc6c45)nc4c3oc3ccccc34)cc2)cc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIM1 P11309 1/20 0.37
CSNK2A2 P19784 1/20 0.37
CSNK2B P67870 1/20 0.37
PIM3 Q86V86 1/20 0.37
PIM2 Q9P1W9 1/20 0.37
ALDH1A1 P00352 5/20 0.33
TSHR P16473 4/20 0.33
HPGD P15428 2/20 0.33
MAPT P10636 10/20 0.32
LMNA P02545 5/20 0.32
KDM4E B2RXH2 3/20 0.32
POLB P06746 3/20 0.32
HSD17B10 Q99714 2/20 0.32
MAPK1 P28482 1/20 0.32
KMT2A Q03164 5/20 0.31
MEN1 O00255 4/20 0.31
NPSR1 Q6W5P4 2/20 0.31
GAA P10253 1/20 0.31
CSF1R P07333 1/20 0.31
PDGFRB P09619 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24118962 0.96 ALDH1A1 (0.34) PIM1CSNK2A2CSNK2BPIM3PIM2
SCHEMBL24118999 0.91 PIM1 (0.35) PIM1CSNK2A2CSNK2BPIM3PIM2
SCHEMBL24388320 0.90 PIM1 (0.37) PIM1CSNK2A2CSNK2BPIM3PIM2
SCHEMBL23740434 0.90 TSHR (0.33) PIM1CSNK2A2CSNK2BPIM3PIM2
SCHEMBL24118955 0.89 PIM1 (0.35) PIM1CSNK2A2CSNK2BPIM3PIM2
SCHEMBL21863121 0.89 NPC1 (0.34) ALDH1A1TSHRHPGDMAPTLMNA
SCHEMBL24119050 0.89 ALDH1A1 (0.35) PIM1CSNK2A2CSNK2BPIM3PIM2
SCHEMBL24388211 0.89 ALDH1A1 (0.36) PIM1CSNK2A2CSNK2BPIM3PIM2
SCHEMBL24118976 0.88 ALDH1A1 (0.33) PIM1CSNK2A2CSNK2BPIM3PIM2
SCHEMBL21863101 0.88 PIM1 (0.36) PIM1CSNK2A2CSNK2BPIM3PIM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210395263-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT EMITTING DIODE COMPRISING SAME, COMPOSITION FOR ORGANIC LAYER OF ORGANIC LIGHT EMITTING DIODE, AND METHOD FOR MANUFACTURING ORGANIC LIGHT EMITTING DIODE LT MATERIALS CO., LTD. (KR) 2021-12-23 US disclosed
EP-3862353-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT EMITTING DIODE COMPRISING SAME, COMPOSITION FOR ORGANIC LAYER OF ORGANIC LIGHT EMITTING DIODE, AND METHOD FOR MANUFACTURING ORGANIC LIGHT EMITTING DIODE LT Materials Co., Ltd. (KR) 2021-08-11 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210395263-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT EMITTING DIODE COMPRISING SAME, COMPOSITION FOR ORGANIC LAYER OF ORGANIC LIGHT EMITTING DIODE, AND METHOD FOR MANUFACTURING ORGANIC LIGHT EMITTING DIODE ODC1, AOX1, CYP1B1 PIM1 1360/4885CSNK2A2 1824/4885CSNK2B 1868/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.